NSF Health Sciences Symposium 2022
16th March 2022 from 13:00 – 17:00 (GMT)
Live online 16th March
A half-day conference with keynotes, fireside chat and simultaneous tracks.
DELEGATES WILL BE FREE TO CHOOSE FROM TRACK 1 or 2 AT ANY TIME.
Welcome
13:00 – 13:10
Welcome and introduction
CLARE FORESTIER | Event Host
PEDRO SANCHA | President and Chief Executive Officer | NSF
Opening
13:10 – 13:25
Keynote and Opening Remarks
HEATHER HOWELL | Global Vice President, Heath Sciences (Acting) | NSF
Fireside Chat
13:25 – 13:50
Fireside Chat
An interview with: ANDERS VINTHER | Vice President, Quality | Kronos Bio
Interviewed by: CLARE FORESTIER | Event Host
13:50- 14:00
Key Takeaways
CLARE FORESTIER | Event Host
Session 1
14:00 – 14:45
The Global Regulatory Landscape – How to best comply?
- How do different regulatory requirements impact the global manufacturer?
- How can manufacturers efficiently fulfil different regulations with one approach?
- What are the real industry needs to be addressed?
- How can post-market activities be addressed by one holistic approach?
- Can Science of Patient Input (SPI) contribute to validating post-market feedback?
Keeping Pace with the Ever-Changing Pharmaceutical Landscape
Once again, the drug manufacturing sector is in transition; with evermore potent molecules and biologics in the pipeline, can regulators keep pace with the speed of change being driven by the pharmaceutical industry?
14:45 – 14:55
Key Takeaways
CLARE FORESTIER | Event Host
Session 2
14:55 – 15:40
Cybersecurity is Critical: Pulling Up the Digital Drawbridge
- Advances in medical device and IVD technology have provided great patient outcomes, but also rising instances of tampering & counterfeiting, cyberattacks & ransomware, supply shortages and technical issues. What practical steps can be taken by manufacturers to protect patients?
- What actions are global regulators taking to prevent adverse events associated with cyber risks, while also facilitating patient access to life-changing innovations?
- Why is it so critical that medical device and IVD cybersecurity regulations be harmonized across the globe?
- How can manufacturers and regulators best communicate cyber risks to patient populations, educating them about the risks and proactive steps they can take to mitigate these risks?
Ensuring Supply Chain Security in a Post-Pandemic World
Recent events have given manufacturers cause to revisit their supply chains.
- What steps can companies take to ensure supply chain security in an increasingly volatile environment?
- Will near-shoring of the supply chain improve processes and what impact will it have on product pricing?
- Elongated lead times are impacting supply. What can companies do to mitigate the issue and to safeguard the supply chain?
John Johnson and guests will look at an issue that has come to the fore in light of recent events such as the Covid-19 related shutdowns.
15:40 – 15:50
Key Takeaways
CLARE FORESTIER | Event Host
Session 3
15:50 – 16:35
Compliance in a Digital World: Preparing for the Challenges of Tomorrow
- How will digitalization, especially artificial intelligence (AI) transform the healthcare industry for manufacturers, regulators and patients?
- Digitalization is driven by agility and constant development. With the increased complexity around AI, which help would you [we] need from regulators to drive innovation while ensuring patient protection?
- How can AI enabled applications such as predictive analytics ensure accuracy and reliability?
- Digitization in all its forms is advancing the interconnection of organizations, products and information. Is the healthcare industry ready for the challenges of tomorrow?
The Increasing Importance of Dietary Supplements in a Post-Covid World
Hockey stick sales growth of dietary supplements in early 2020, with an increase in the USA in sales of $435million in a six-week period[1], has cast a spotlight on the sector. In this session, chaired by NSF’s Casey Coy, we ask:
- Is the unprecedented growth in dietary supplements here to stay?
- What can companies do to stand apart from competitors in such a crowded marketplace?
- What does the industry need to do collectively to ensure build confidence in products?
- Casey will be joined by industry leaders from Herbalife, Garden of Life, ClearCut Analytics, the Global Prebiotic Association and Informa Markets to discuss these issues, and more.
16:35 – 16:45
Key Takeaways
CLARE FORESTIER | Event Host
16:45 – 16:55
Closing remarks
HEATHER HOWELL | Global Vice President, Health Sciences (Acting) | NSF
16:55 – 17:00
Thank you and close
CLARE FORESTIER | Event Host
13:00 – 13:10
Welcome and Introductions
Clare Forestier | Event Host
PEDRO SANCHA | President and Chief Executive Officer | NSF
13:10 – 13:25
Keynote and Opening Remarks
HEATHER HOWELL | Global Managing Director | Health Sciences Training Medical Devices | NSF
13:25 – 13:50
Fireside Chat
An interview with Anders Vinther, Vice President, Quality, Kronos Bio
Interviewed by Clare Forestier | Event Host
14:00 – 14:45
Session 1:
The Global Regulatory Landscape: How to best comply?
- How do different regulatory requirements impact the global manufacturer?
- How can manufacturers efficiently fulfil different regulations with one approach
- What are the real industry needs to be addressed?
- How can post-market activities be addressed by one holistic approach?
- Can Science of Patient Input (SPI) contribute to validating post-market feedback?
14:55 – 15:40
Session 2:
Cybersecurity is Critical: Pulling Up the Digital Drawbridge
- Advances in medical device and IVD technology have provided great patient outcomes, but also rising instances of tampering & counterfeiting, cyberattacks & ransomware, supply shortages and technical issues. What practical steps can be taken by manufacturers to protect patients?
- What actions are global regulators taking to prevent adverse events associated with cyber risks, while also facilitating patient access to life-changing innovations?
- Why is it so critical that medical device and IVD cybersecurity regulations be harmonized across the globe?
- How can manufacturers and regulators best communicate cyber risks to patient populations, educating them about the risks and proactive steps they can take to mitigate these risks?
15:50 – 16:35
Session 3:
Compliance in a Digital World: Preparing for the Challenges of Tomorrow
- How will digitalization, especially artificial intelligence (AI) transform the healthcare industry for manufacturers, regulators and patients?
- Digitalization is driven by agility and constant development. With the increased complexity around AI, which help would you [we] need from regulators to drive innovation while ensuring patient protection?
- How can AI enabled applications such as predictive analytics ensure accuracy and reliability?
- Digitization in all its forms is advancing the interconnection of organizations, products and information. Is the healthcare industry ready for the challenges of tomorrow?
16:45 – 16:55
Closing Remarks
HEATHER HOWELL | Global Managing Director | Health Sciences Training Medical Devices | NSF
TRACK 2
Pharma, DS and Clinical
14:00 – 14:45
Session 1:
Keeping Pace with the Ever-Changing Pharmaceutical Landscape
Once again, the drug manufacturing sector is in transition; with evermore potent molecules and biologics in the pipeline, can regulators keep pace with the speed of change being driven by the pharmaceutical industry?
14:55 – 15:40
Session 2:
Ensuring Supply Chain Security in a Post-Pandemic World
Recent events have given manufacturers cause to revisit their supply chains.
- What steps can companies take to ensure supply chain security in an increasingly volatile environment?
- Will near-shoring of the supply chain improve processes and what impact will it have on product pricing?
- Elongated lead times are impacting supply. What can companies do to mitigate the issue and to safeguard the supply chain?
John Johnson and guests will look at an issue that has come to the fore in light of recent events such as the Covid-19 related shutdowns.
15:50 – 16:35
Session 3:
The Increasing Importance of Dietary Supplements in a Post-Covid World
Hockey stick sales growth of dietary supplements in early 2020, with an increase in the USA in sales of $435million in a six-week period[1], has cast a spotlight on the sector. In this session, chaired by NSF’s Casey Coy, we ask:
- Is the unprecedented growth in dietary supplements here to stay?
- What can companies do to stand apart from competitors in such a crowded marketplace?
- What does the industry need to do collectively to ensure build confidence in products?
- Casey will be joined by industry leaders from Herbalife, Garden of Life, ClearCut Analytics, the Global Prebiotic Association and Informa Markets to discuss these issues, and more.
16:45 – 16:55
Closing Remarks
HEATHER HOWELL | Global Managing Director | Health Sciences Training Medical Devices | NSF
Sign up for life science integrates news
Get the latest news and updates by signing up today.
By signing up to the life science integrates newsletter, you have read and agree to our Privacy Policy, including our Cookie use.